Mitochondrial dysfunction and beneficial effects of mitochondria-targeted small peptide SS-31 in Diabetes Mellitus and Alzheimer’s disease-Reference-Cited by-同舟云学术

Mitochondrial dysfunction and beneficial effects of mitochondria-targeted small peptide SS-31 in Diabetes Mellitus and Alzheimer’s disease

Published:2021-09 Issue: Volume:171 Page:105783
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Ding Xiao-Wen^ORCID,Robinson Megan,Li Rongzi,Aldhowayan Hadeel,Geetha Thangiah,Babu Jeganathan Ramesh

Funder

Alabama Agricultural Experiment Station

Publisher

Elsevier BV

Subject

Pharmacology

Reference256 articles.

1. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications;Zheng;Nat. Rev. Endocrinol.,2018

2. Centers for Disease Control and Prevention, National diabetes statistics report, 2017, Atlanta, GA.

3. Mitochondrial dysfunction and oxidative stress in metabolic disorders – a step towards mitochondria based therapeutic strategies;Bhatti;Biochim Biophys. Acta Mol. Basis Dis.,1863

4. Dynamics of diabetes and obesity: epidemiological perspective;Boles;Biochim Biophys. Acta Mol. Basis Dis.,1863

5. Is Alzheimer’s disease a type 3 diabetes? A critical appraisal;Kandimalla;Biochim Biophys. Acta Mol. Basis Dis.,1863

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondria-targeting near-infrared (NIR) materials orchestrating the symphony of precision diagnosis and therapy;Nano Today;2024-12

2. Drug Target to Alleviate Mitochondrial Dysfunctions in Alzheimer’s Disease: Recent Advances and Therapeutic Implications;Current Neuropharmacology;2024-10

3. Exploring the Mechanisms and Therapeutic Approaches of Mitochondrial Dysfunction in Alzheimer’s Disease: An Educational Literature Review;Molecular Neurobiology;2024-09-10

4. SS-31 mitigates oxidative stress and restores mitochondrial function in cigarette smoke-damaged oral epithelial cells via PINK1-mediated mitophagy;Chemico-Biological Interactions;2024-09

5. SS-31 protects diabetic nephropathy progression: A systematic review of in vivo and in vitro studies;Journal of Pharmacy & Pharmacognosy Research;2024-09-01